Skip to content

Implementation of a new treatment scheme for primary knee prosthesis implantations in the German health care system in collaboration with DRV

Implementation of a new treatment scheme for primary knee prosthesis implantations in the German health care system in collaboration with DRV

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00032695
Enrollment
70
Registered
2023-10-02
Start date
2023-08-30
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient with advanced osteoarthritis and indication for endoprosthetic joint replacement of the knee joint (knee TEP)

Interventions

Group 1: Group 1: - Opti Track Athletic group: patients undergo the Fast Track program and Athletic treatment regimen during the clinical stay, with pre-rehabilitation and two-phase rehabilitation wit

Sponsors

Medizinische Hochschule Hannover
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: - Indication for primary implantation of a total knee joint endoprosthesis - Age: 18 - 80 years - Patient is gainfully employed

Exclusion criteria

Exclusion criteria: - ASA 3-6 - BMI > 34 kg/m2 - Diabetes mellitus with blood glucose imbalances (hypoglycemias) - Chronic renal insufficiency with GFR < 60 (stage III according to NKF) - Coronary artery disease with Z.n. intervention within the last 2 years or further complaints - Permanent anticoagulation with heart valve replacement - Dementia or other neurological diseases with alteration of gait (Parkinson's syndrome, myasthenia gravis, visual pathway disorders, etc.) - Anemia/hemophilia/thrombophilia with secondary DVT/LAE - Known depression/psychoaffective disorder - Chronic pain patient with long-term opioid medication/fibromyalgia - Rheumatoid arthritis with expected limitation in postoperative mobilization - COPD with limitations in daily living/sleep apnea syndrome - Massive ROM deficit - Lack of compliance for complex treatment procedures - Language barrier Subsequent exclusion from clinical trial: - Loss of assignment to OptiTrack Athletic group and continued treatment according to standard (time: until discharge).

Design outcomes

Primary

MeasureTime frame
Comparison of the Knee Injury and Osteoarthritis Score including Western Ontario and McMaster Universities Osteoarthritis Index (KOOS including WOMAC) score after 3 months, reflecting the functionality and quality of life of patients who underwent two different treatment regimens. We expect a superiority, in terms of postoperative outcome, of the Athletic group over the Classic group. The study will be considered successful if this superiority can be demonstrated.

Secondary

MeasureTime frame
- Acquisition and comparison KOOS six, twelve and 24 months postoperatively - Acquisition of PROMS University of California Los Angeles Activity Score (UCLA), Oxford Knee Score (OKS), Knee Society Score (KSS), Forgotten Joint Score (FJS), European Quality of Life 5 Dimensions 5 Level (EQ-5D-5L), Chronic Pain Grade according to von Korff ( CPG n. v. Korff), Depression Anxiety Stress Scales (DASS) - Assessment of pain via Visual Analog Scale (VAS) - Measurement of the knee joint extension force (M. quadriceps femoris) via dynamometer - Recording of postoperative complications - Recording of the readmission rate - Assessment of the effect of the two treatment regimens on obesity, diabetes mellitus type II, chronic pain syndrome - Assessment of the effects of the two treatment regimens on the time of complete reintegration into the profession or on the time of resumption of the profession or occupation, respectively.

Countries

Germany

Contacts

Public ContactYvonne Noll

Orthopädische Klinik der Medizinischen Hochschule Hannover im Diakovere Annastift

Yvonne.Noll@diakovere.de+49 511 5354 649

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026